UBE2I and pachyonychia congenita: SUMO1, Uba2, and Ubc9 upregulation in PCs could lead to enhanced SUMOylation of the TF ETS variant 1 (ETV1), and blocking ETV1 tumor-promoting activity by SUMOylation could suppress the growth of PC (Oh et al., 2021).